U.S. Strengthens PFAS Pollution Regulation in Seafood
The U.S. Food and Drug Administration (FDA) has increased its focus on persistent organic pollutants (PFAS) in seafood. PFAS are a group of chemicals known for their heat, water, and grease resistance, widely used in various consumer products such as waterproof clothing, food packaging, and cookware. Studies indicate that PFAS can remain in the environment for hundreds of years, earning them the nickname "forever chemicals."
In July 2022, Bumble Bee Foods, a well-known canned seafood company, voluntarily recalled its smoked clam products imported from China after the FDA detected measurable levels of PFAS. This incident prompted regulators to intensify scrutiny of imported seafood. Following tests on 81 samples, including canned clams, the FDA found that PFAS levels in some samples could pose risks to human health.
Since then, the FDA has continued to investigate the potential links between PFAS and human health and released a Request for Information (RFI) in November this year concerning PFAS in seafood, aiming to collect scientific data from the seafood industry and related experts. This data includes information on PFAS concentrations in seafood, surrounding environments, and processing water, seeking methods to reduce exposure risks.
According to a briefing from the American law firm Akin, the FDA has been testing for PFAS in the overall food supply since 2019, with most samples coming from its Total Diet Study (TDS) project, which monitors the nutritional content and pollutant levels in food. Data shows that over 97% of fresh and processed food samples tested in the TDS did not detect PFAS, while 51% of seafood samples contained at least one PFAS. This percentage rose to 74% in the FDA's 2022 seafood survey.
Despite data indicating that seafood may be more susceptible to PFAS contamination than other foods, current data remains limited. The FDA has yet to decide whether to establish a minimum tolerance level for PFAS in seafood, similar to the standards for mercury levels in tuna. FDA experts believe that the current focus is on obtaining more reliable data to support future decisions.
Akin partner Nathan Brown pointed out that the FDA's focus on PFAS indicates that the issue has become a priority; however, due to insufficient information, specific regulatory measures have yet to be established. He anticipates that the FDA may take more cautious steps, such as issuing safety advisories or prioritizing testing, rather than directly establishing mandatory exposure standards.
Lisa Wallenda Picard, president of the National Fisheries Institute (NFI), urged food and beverage manufacturers to closely monitor the latest scientific developments regarding "forever chemicals." She emphasized that despite the many unknowns, the food industry has a responsibility to seek and implement feasible solutions.
In this context, some U.S. seafood suppliers have begun taking proactive measures. The Alaska Seafood Market Research Institute (ASMI) recently completed a federally funded multi-year project that tested 11 seafood products from key fisheries in Alaska for nutrients and contaminants, including heavy metals, radiation, and PFAS. The project analyzed nearly 600 fish samples and found PFAS levels to be far below any concerning thresholds. ASMI's Technical Director John Burrows revealed that the final report will be released this month, providing detailed data for the seafood industry.
2026-10-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
GM Crop Area Reaches 216 Million Hectares
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
GM Crop Area Reaches 216 Million Hectares
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
Recommend Reading
-
UK’s £350 Million Critical Chemicals Fund Enters Formal Review, Offering Up to 50% Support Per Project
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
Business Society’s Acrylic Acid Trend Analysis on September 18, 2026: Strong Consolidation
-
In 2025, China's hydrofluoric acid prices fluctuated upward; in 2026, the price level may continue to rise
-
Business Society’s Diesel Trend Analysis for September 11, 2026: Stagnation and Inflation Warning
-
Weak demand leads to consolidation in China's anhydrous hydrogen fluoride market
-
2025 Toluene Market Fluctuates Downward, 2026 Supply and Demand Competition Outlook